runner,
it will work like this, they will partner it out in specific regions ie US, Euorope and Asia for example to bigger pharma's this year more than likely and now with it being run on the National news the other News bodies around the world will pick it up and run with it, thus making an aussie bio known worldwide for its oxy patch
Based on other benchmarked deals in the pharmaceutical industry and the development stage of Phase II, one could envision an arrangement with a tiered royalty of 5-15 % based on total annual sales plus cash milestones in the range of about $100 million dollars in total, these cash milestones that POH always talks about would be paid in increments on completion of a development event such as phase II, phase III, or a filing, or upon approval etc and so on.
The upfront payment on contract signature could range from about $3-10 million dollars (estimate about middle of those two figures). These figures and deal structure would all be part of the negotiation of the agreement and may vary based on perceived risk and how much is paid in cash vs. royalty. So in essence the more they get up front the lower the ongoing royalty.
The actual sales of the product could range between about $500 million to well over $1 billion dollars or more per year (this is also dependent on the indication and label given by the Regulatory authorities, and the marketing program put behind it. )
So POH may sign licencing deals for regions for oxy during the next few months etc. And this is only one of the Pipeline
It wont matter when they get it set for Retail sales as this will happen with a big pharma behind it as long as they do 11/111's, again what needs to be remembered is that this is not a new drug its already being used, and Phase 1b exceeded their expectations which is why it got a run on the Channel 7 News tonight
And that is very hard to do, especially for a little Aussie BIO
We need to think Cochlear and how much a world first that was and thats what we are seeing tonight, Cochlear are now in 100 countries world wide
Hope this helps
- Forums
- ASX - By Stock
- remember the science base
runner,it will work like this, they will partner it out in...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
-0.001(16.7%) |
Mkt cap ! $7.923M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.265K | 506.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
56 | 91768918 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 60002650 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
56 | 91768918 | 0.002 |
19 | 67595009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 60002650 | 20 |
0.004 | 17587707 | 17 |
0.005 | 22033532 | 10 |
0.006 | 19255067 | 9 |
0.007 | 5722471 | 6 |
Last trade - 12.19pm 28/08/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online